title: Roles of reactive oxygen and nitrogen species in pain.
abstract: Peroxynitrite (PN; ONOO⁻) and its reactive oxygen precursor superoxide (SO; O₂•⁻) are critically important in the development of pain of several etiologies including pain associated with chronic use of opiates such as morphine (also known as opiate-induced hyperalgesia and antinociceptive tolerance). This is now an emerging field in which considerable progress has been made in terms of understanding the relative contributions of SO, PN, and nitroxidative stress in pain signaling at the molecular and biochemical levels. Aggressive research in this area is poised to provide the pharmacological basis for development of novel nonnarcotic analgesics that are based upon the unique ability to selectively eliminate SO and/or PN. As we have a better understanding of the roles of SO and PN in pathophysiological settings, targeting PN may be a better therapeutic strategy than targeting SO. This is because, unlike PN, which has no currently known beneficial role, SO may play a significant role in learning and memory. Thus, the best approach may be to spare SO while directly targeting its downstream product, PN. Over the past 15 years, our team has spearheaded research concerning the roles of SO and PN in pain and these results are currently leading to the development of solid therapeutic strategies in this important area.
authors.affiliation: Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, MO 63104, USA. salvemd@slu.edu
authors.forename: Daniela
authors.initials: D
authors.lastname: Salvemini
authors.forename: Joshua W
authors.initials: JW
authors.lastname: Little
authors.forename: Timothy
authors.initials: T
authors.lastname: Doyle
authors.forename: William L
authors.initials: WL
authors.lastname: Neumann
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D015195:Drug Design; D006801:Humans; D058990:Molecular Targeted Therapy / Q000639:trends; D020078:Neurogenic Inflammation; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology; D030421:Peroxynitrous Acid / Q000378:metabolism; D026361:Reactive Nitrogen Species / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D013481:Superoxides / Q000378:metabolism
chemical_list: D000700:Analgesics; D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species; D013481:Superoxides; D030421:Peroxynitrous Acid